首页|AHV-PI抗血小板聚集的PI3K/Akt信号通路机制研究

AHV-PI抗血小板聚集的PI3K/Akt信号通路机制研究

扫码查看
目的 探讨蝮蛇毒血小板抑制因子(AHV-PI)抗血小板聚集的细胞内信号转导通路及其可能机制.方法 通过蛋白质免疫印迹(Western blot)检测AHV-PI对血小板内Akt蛋白激酶磷酸化水平情况,XS-1000I五分类血球计数仪进行血小板计数;酶联免疫吸附法(ELISA)测定家兔血浆中5'-核苷酸酶(5'-NT),血小板膜糖蛋白Ib(GPIb)含量;流式细胞术(FCM)观察AHV-PI对荧光标记的单克隆抗体CD61(FITC-CD61)与血小板膜糖蛋白Ⅱb/Ⅲa(GPⅡb/Ⅲa)结合率的影响.结果 AHV-PI能降低Akt磷酸化水平,减少血小板数量,升高血浆中5'-NT含量,降低血小板GPIb的表达;AHV-PI对单克隆抗体CD61与血小板的结合率没有影响.结论 AHV-PI可以通过抑制蛋白激酶Akt磷酸化来阻断Akt通路的信号转导,限制细胞生长,减少血小板数量;具有5'-核苷酸酶的活性,能够降解ADP,防止血小板性血栓的形成.
Study on the mechanism of AHV-PI on platelet aggregation by PI3K/Akt signal pathway
Objective To investigate the mechanism of platelet inhibitor from Agkistrodon halys venom (AHV-PI) on platelet aggregation. Methods Protein kinase Akt phosphorylation levels in platelet were measured by Western blot. XS-1000I blood cell counter was used for platelet count. The plasma content of 5'-NT and platelet membrane GPIb were determined by Enzyme-Linked Immunosorbnent Assay (ELISA). The effect of AHV-PI on binding rate between the fluorescence labeled monoclonal antibody CD61 (FITC-CD61) and platelet membrae glycoprotein Ⅱb/Ⅲa (GPⅡb/Ⅲa) was observed by flow cytometry (FCM). Results AHV-PI can reduce the level of Akt-phosphorylation level and the number of platelet. AHV-PI can increase the content of 5'-NT in plasma, reduce the expression of platelet GPIb. Flow cytometry displayed AHV-PI can not affect the rate of combination between platelet GPⅡb/Ⅲa and FITC-CD61. Conclusion The mechanism of inhibition of platelet aggregation may be inhibit protein kinase Akt phosphorylation to block the signal transduction pathway of Akt. Limit cell grouth and reduce platelet number, also it may be related to its 5'-NT activity, it can degradate ADP to prevent the formation of platelet thrombus.

Agkistrodon halys venomplatelet inhibitorprotein kinase

季娜、张根葆、周淑艳

展开 >

皖南医学院 组织胚胎学教研室,安徽 芜湖 241000

皖南医学院 病理生理学教研室,安徽 芜湖 241000

皖南医学院 蛇毒研究所,安徽 芜湖 241000

蝮蛇毒 抗血小板聚集 蛋白激酶

2016年度活性生物大分子研究安徽省重点实验室自主研究课题

LAB201606

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(1)
  • 6